Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin, indicated as an adjunct to diet and exercise to improve glycaemic control (blood sugar) in adults living with type 2 diabetes.
The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I). Kresladi is indicated for the treatment of pediatric patients with severe leukocyte adhesion deficiency I (LAD-I) due to biallelic variants in ITGB2 without an available human leukocyte antigen (HLA)-matched sibling donor for allogeneic hematopoietic stem cell transplant.
The objective of this component of the study is to estimate the national as well as subnational burden of NCDs in India using an integrated approach combining available health surveys, administrative data, and advanced statistical model as well as machine leaning methods.
Ph.D. in Chemical Science or M.Pharm. from a recognized university or equivalent. and 2 years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations and Scientific activities and services
IISc welcomes the Masters / PhD / Postdoctoral researchers of recognised Foreign Institutes / Universities for short-term visiting program across its departments / centres.
Ph.D in Biotechnology / Life / Biological Science from a recognized university or equivalent. Work Experience in development & characterization of transgenics, protein interaction studies, NGS data analysis, etc. as evident from publications in peer reviewed journals.
Ph.D. in the relevant subject / With Masters degree holders: Masters degree in the relevant subject with 4/5 years of Bachelors degree having 1st division or 60% marks or equivalent
Post Graduate Degree in Life Sciences / Public Health including the integrated PG degrees, with three years post qualification Experience (Maternal health research and field work in tribal population) or PhD.
Post Graduate Degree, including the integrated PG degrees, candidates with demonstrated experience in drug delivery, polymer science, and biomaterials-based therapeutic systems for gastrointestinal diseases
Masters degree in Bioinformatics or Biotechnology with Bachelors degree in any life science discipline, preference will be given to candidate with plant genomics background Candidates must have a minimum of 60% marks in postgraduation.
Experience and expertise in authoring, compiling and submission of country specific submissions (MAA,BLA, and post approval changes) of Biologics/Biosimilar products in various markets- Regulated (EU/US/Canada) and emerging markets.